The FTSE 100 could trump the S&P 500 in 2025. Here’s why

Over the past year, the main FTSE stock market’s gained 10.5%. By contrast, the S&P 500‘s up 31.4% over the same period. The difference in performance has been pretty stark, leading some investors to think about allocating more money to US stocks next year. Here’s why I don’t think this is the best idea.

Strong gains in 2024

One factor why the S&P 500’s done so well is the rise of artificial intelligence (AI) as a key investing theme. The US stock market’s home to many of the largest tech companies and firms that are leading the way in terms of AI development.

Another influence has been US economic performance versus the UK. For example, the Q3 2024 GDP growth rate for the US was 2.8%. By contrast, it was just 0.1% for the UK. Given that the stock market’s a key barometer for the economy, it doesn’t surprise me given those figures that one market has really outperformed the other.

Finally, the recent election result in the US has provided a final quarter surge in stocks. President-elect Trump is seen as pro-business, with potential for deregulation and easing corporate red tape.

Looking ahead

I think 2025 will be different. The current price-to-earnings ratio of the S&P 500 is 31.17. For the FTSE 100 it’s 15.5. Put another way, the US market’s twice as expensive as the UK. So from my perspective, I struggle to see the US beating the UK next year as the valuations just don’t match up.

The election victory might have given US stocks a boost in the short term, but there are implications for next year. The likely surge in fiscal spending could be inflationary, forcing the Federal Reserve to keep interest rates higher for longer. This shift could spook US investors, causing the stock market to fall.

In the UK, inflation’s been around the target 2% for six months. This bodes well for further interest rate cuts next year. As a result, a lower base rate could help to spark a boom in economic activity which has been missing in 2024. If seen, I’d expect UK stocks to feel the benefit.

A potential benefactor

As an example of a UK stock that could do well from lower interest rates, investors can consider Target Healthcare REIT (LSE:THRL). The investment trust share price is up 5% over the past year, with a current dividend yield of 6.61%.

The trust holds a portfolio primarily focused on care homes and other healthcare-related properties. It buys, manages and sells properties, aiming to benefit from income made from leasing them out. When it purchases a new site, some of this is funded by debt. As a result, lower interest rates in the future should ease the funding costs.

Please note that tax treatment depends on the individual circumstances of each client and may be subject to change in future. The content in this article is provided for information purposes only. It is not intended to be, neither does it constitute, any form of tax advice.

With commercial property values in the UK still in a bit of a slump, a spark in activity next year could increase the value of Target Healthcare’s portfolio. At the moment, the share price trades at a 26% discount to the portfolio net asset value (NAV). The stock could rally next year to close this discount.

A risk is that healthcare properties is quite niche. The business isn’t diversified across other types of property usage, which some investors might see as a problem.

The post The FTSE 100 could trump the S&P 500 in 2025. Here’s why appeared first on The Motley Fool UK.

Should you invest £1,000 in Target Healthcare Reit Plc right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets.

And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Target Healthcare Reit Plc made the list?

See the 6 stocks

More reading

Jon Smith has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.